Imricor Medical Systems (ASX:IMR) Days Sales Outstanding : 113.07 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Imricor Medical Systems Days Sales Outstanding?

Imricor Medical Systems's average Accounts Receivable for the six months ended in Dec. 2023 was A$0.39 Mil. Imricor Medical Systems's Revenue for the six months ended in Dec. 2023 was A$0.62 Mil. Hence, Imricor Medical Systems's Days Sales Outstanding for the six months ended in Dec. 2023 was 113.07.

The historical rank and industry rank for Imricor Medical Systems's Days Sales Outstanding or its related term are showing as below:

ASX:IMR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.3 Med: 88.4 Max: 153.54
Current: 126.82

During the past 6 years, Imricor Medical Systems's highest Days Sales Outstanding was 153.54. The lowest was 48.30. And the median was 88.40.

ASX:IMR's Days Sales Outstanding is ranked worse than
86% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 64.66 vs ASX:IMR: 126.82

Imricor Medical Systems's Days Sales Outstanding declined from Dec. 2022 (115.17) to Dec. 2023 (113.07).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Imricor Medical Systems Days Sales Outstanding Historical Data

The historical data trend for Imricor Medical Systems's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imricor Medical Systems Days Sales Outstanding Chart

Imricor Medical Systems Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

88.40

130.80

80.47

48.30

153.54

Imricor Medical Systems Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial				91.65	55.51	115.17	114.29	113.07

Competitive Comparison of Imricor Medical Systems's Days Sales Outstanding

For the Medical Devices subindustry, Imricor Medical Systems's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Imricor Medical Systems's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Imricor Medical Systems's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Imricor Medical Systems's Days Sales Outstanding falls into.

Imricor Medical Systems Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Imricor Medical Systems's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.187	+	0.587)	/	2 )	/	0.92	*	365
=	0.387					/	0.92	*	365
=	153.54

Imricor Medical Systems's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.185	+	0.587)	/	2 )	/	0.623	*	365 / 2
=	0.386					/	0.623	*	365 / 2
=	113.07

Imricor Medical Systems (ASX:IMR) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Imricor Medical Systems Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Imricor Medical Systems's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Imricor Medical Systems (ASX:IMR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imricor Medical Systems Inc (ASX:IMR) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

400 Gateway Boulevard, Burnsville, MN, USA, 55337

Website

https://www.imricor.com

Imricor Medical Systems Inc is a medical device company engaged in addressing issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. The products of the company include Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode.

Imricor Medical Systems (ASX:IMR) Headlines

No Headlines